XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
The following table presents information about the fair value measurement of the Company’s financial instruments (in thousands):
  
As of December 31,
Financial Instruments Recorded at Fair Value on a Recurring Basis:Fair Value Measurement Level20232022
Assets:
Derivative assets—foreign currency contracts (1)
2$76 $— 
Derivative assets—interest rate swap contract (2)
216,248 23,410 
Total assets$16,324 $23,410 
Liabilities:
Derivative liabilities—foreign currency contracts (3)
2$— $1,001 
Contingent consideration—earn out (4)
315,000 22,747 
Total liabilities$15,000 $23,748 
(1)Included in prepaid expenses and other current assets in the accompanying consolidated balance sheets.
(2)Included in prepaid expenses and other current assets and other non-current assets in the accompanying consolidated balance sheets.
(3)Included in other current liabilities in the accompanying consolidated balance sheets.
(4)Included in current and non-current contingent consideration in the accompanying consolidated balance sheets.
Transfers of assets and liabilities among Level 1, Level 2 and Level 3 are recorded as of the actual date of the events or change in circumstances that caused the transfer. For the years ended December 31, 2023 and 2022, there were no transfers between levels of the fair value hierarchy of the Company’s assets or liabilities measured at fair value.
The fair value of the Company’s derivative assets and liabilities through its foreign currency contracts is based upon observable market-based inputs that reflect the present values of the differences between estimated future foreign currency rates versus fixed future settlement prices per the contracts, and therefore, are classified within Level 2. The fair value of the Company's interest rate swap contract held with a financial institution is classified as a Level 2 financial instrument, which is valued using observable underlying interest rates and market-determined risk premiums at the reporting date.
On November 10, 2022, the Company entered into the second amendment to the share purchase agreement associated with the Apption Labs business combination to extend the earn out period through the end of fiscal year 2023. This amendment also modified the contingent consideration calculation associated with the achievement of certain revenue, earnings, and successful product launch thresholds for fiscal years 2022 and 2023. The remaining amount the Company expects to pay under the contingent consideration arrangement is $15.0 million, becoming due during the first half of fiscal year 2024.
The fair values of the Company's contingent consideration earn out obligation was estimated using a Black Scholes model. Key assumptions used in these estimates include the weighted average cost of capital and the probability assessments with respect to the likelihood of achieving the forecasted performance targets consistent with the level of risk of achievement. As these are significant unobservable inputs, the contingent consideration earn out obligation is included in Level 3 inputs.
At each reporting date, the Company revalues the contingent consideration obligation to its fair value and records increases and decreases in fair value in the change in fair value of contingent consideration in the accompanying consolidated statements of operations and comprehensive loss. Changes in the fair value of the contingent consideration obligation results from changes in discount periods and rates, and changes in probability assumptions with respect to the likelihood of achieving the performance targets.
The following table presents the fair value of contingent consideration (in thousands):
Year-ended December 31,
202320222021
Contingent consideration, beginning of period
$22,747 $25,300 $— 
Acquisition date fair value of contingent consideration
— — 21,500 
Payments of contingent consideration(12,445)(12,555)— 
Change in fair value of contingent consideration
4,698 10,002 3,800 
Contingent consideration, end of period
$15,000 $22,747 $25,300 
The following table reconciles the changes in fair value of contingent consideration and payments of contingent consideration to the accompanying consolidated statement of cash flows and consolidated statements of operations and comprehensive loss (in thousands):
Year-ended December 31,
202320222021
Total payment of contingent consideration
$12,445 $12,555 $— 
Less: amounts paid in excess of the acquisition date fair value of the contingent consideration (1)
(220)(3,280)— 
Acquisition date fair value of contingent consideration (2)
$12,225 $9,275 $— 
Change in fair value of contingent consideration (3)
$4,698 $10,002 $3,800 
Less: amounts paid in excess of the acquisition date fair value of the contingent consideration (1)
(220)(3,280)— 
Net change in fair value of contingent consideration (4)
$4,478 $6,722 $3,800 
(1)Included in the change in fair value of contingent consideration as an operating activity in the accompanying consolidated statement of cash flows.
(2)Agrees to the payments of acquisition related contingent consideration as a financing activity within the accompanying consolidated statement of cash flows.
(3)Agrees to the change in fair value of contingent consideration in the accompanying consolidated statement of operations and comprehensive loss.
(4)Agrees to the change in fair value of contingent consideration as an operating activity in the accompanying consolidated statement of cash flows.
The following financial instruments are recorded at their carrying amount (in thousands):
 
As of December 31, 2023
As of December 31, 2022
Financial Instruments Recorded at Carrying Amount:Carrying
Amount
Estimated
Fair Value
Carrying
Amount
Estimated
Fair Value
Liabilities:
Debt—Credit Facilities (1)
$403,825 $357,498 $476,070 $393,236 
Total liabilities$403,825 $357,498 $476,070 $393,236 
(1)Included in the current portion of notes payable and notes payable, net of current portion in the accompanying consolidated balance sheets. Due to the unobservable nature of the inputs these financial instruments are considered to be Level 3 instruments in the fair value hierarchy